<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>503A and 503B | Clinical Pharmacology Learning</title>
  <style>
    body {
      font-family: 'Helvetica Neue', Arial, sans-serif;
      background-color: #f8fafc;
      color: #1e293b;
      margin: 0;
      padding: 0;
    }
    header {
      background-color: #003366;
      color: white;
      text-align: center;
      padding: 1.5rem 0;
      font-size: 1.5rem;
      letter-spacing: 0.5px;
    }
    nav {
      background-color: #e6e9ef;
      display: flex;
      justify-content: center;
      gap: 1.5rem;
      padding: 1rem 0;
    }
    nav a {
      text-decoration: none;
      color: #003366;
      font-weight: bold;
    }
    nav a:hover {
      text-decoration: underline;
    }
    main {
      max-width: 900px;
      margin: 2rem auto;
      padding: 1rem;
    }
    section {
      background: white;
      border-radius: 10px;
      box-shadow: 0 0 5px rgba(0,0,0,0.1);
      padding: 1.5rem;
      margin-bottom: 2rem;
    }
    h2 {
      color: #003366;
      margin-bottom: 1rem;
    }
    ul {
      margin-left: 1.5rem;
      margin-bottom: 1rem;
    }
    li {
      margin-bottom: 0.7rem;
    }
    footer {
      margin-top: 2rem;
      text-align: center;
      font-size: 0.9rem;
      color: #64748b;
      padding-bottom: 2rem;
    }
    .back-link {
      display: inline-block;
      margin-bottom: 1rem;
      color: #00509e;
      text-decoration: none;
      font-weight: bold;
    }
    .back-link:hover {
      text-decoration: underline;
    }
  </style>
</head>
<body>

  <header>
    503A and 503B | Clinical Pharmacology
  </header>

  <nav>
    <a href="../index.html">Home</a>
    <a href="../glossary.html">Glossary</a>
    <a href="../pk.html">PK</a>
    <a href="../pd.html">PD</a>
    <a href="../trial.html">Trial Design</a>
    <a href="../resources.html">Resources</a>
  </nav>

  <main>
    <a href="../glossary.html" class="back-link">&larr; Back to Glossary Index</a>

    <section>
      <h2>Overview</h2>
      <p>These refer to sections of the FD&C Act describing two categories of compounding pharmacies:</p>
      <ul>
        <li><strong>503A – Traditional Compounding Pharmacies:</strong> Local/community pharmacies that compound drugs for individual patients based on prescriptions. Regulated by state boards; patient-specific; not for bulk or resale.</li>
        <li><strong>503B – Outsourcing Facilities:</strong> Larger facilities producing sterile drugs in bulk without individual prescriptions. Must register with FDA, follow cGMP, and undergo inspections.</li>
      </ul>
    </section>

    <section>
      <h2>Key Differences from FDA-approved Drugs</h2>
      <ul>
        <li>FDA-approved drugs: NDA/ANDA required, full clinical trials for safety & efficacy, commercially mass-produced.</li>
        <li>503B compounded drugs: No NDA/ANDA, cGMP compliance, sterility & potency testing, used for shortages or hospital-specific needs.</li>
      </ul>
    </section>

    <section>
      <h2>Clinical Pharmacology Relevance</h2>
      <ul>
        <li>503A: Individualized therapy; may affect PK/PD due to excipient changes.</li>
        <li>503B: Quality-controlled; batch testing reduces variability but efficacy not formally proven.</li>
        <li>Clinical trials require GMP-compliant drugs; 503B may be used under sponsor oversight, 503A cannot.</li>
      </ul>
    </section>

    <section>
      <h2>Risks and Safety</h2>
      <ul>
        <li>503B drugs can cause adverse events: contamination, dosing errors, excipient incompatibility, allergic reactions.</li>
        <li>Adverse events must be reported via FDA MedWatch.</li>
        <li>Historical incidents (e.g., NECC 2012) led to 503B regulation under the Drug Quality and Security Act 2013.</li>
      </ul>
    </section>

    <section>
      <h2>Comments / Feedback</h2>
      <p>Visitors can leave suggestions or corrections here. (Future: integrate Disqus, GitHub Discussions, or another commenting system)</p>
    </section>
  </main>

  <footer>
    © 2025 Crystal B. Yeung | ClinPharmacology.com
  </footer>

</body>
</html>
